Paul Scigalla's Insider Trades & SAST Disclosures

Paul Scigalla's most recent trade in Genelux Corp was a trade of 16,666 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 18, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Genelux Corp
Paul Scigalla Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2024 16,666 16,666 - - Stock Option (right to buy)
Genelux Corp
Paul Scigalla Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2024 16,666 16,666 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades